admin, Author at PsyNews.com

Home Authors Posts by admin

2168 POSTS 0 COMMENTS

https://psynews.com

Colorado’s Draft Natural Medicine Rules: Full Breakdown & Commentary

Colorado’s Draft Natural Medicine Rules: A High-Level Overview

PT489 – Psychedelics, Art Therapy, and the Creative Process

Ibogaine Advocates Seek Ohio Opioid Settlement Funds Following Failure in Kentucky

Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan...

PT488 – The Cost of War: Veterans’ Mental Health and Government...

Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of...

PT487 – Interoception, Healing Through Connection, and Learning to Trust Our...

Pα+: Day 2 Dispatch from ‘Advancing Psychedelic Clinical Study Design’, Hosted...

Opinion: How Ayahuasca Could Change You

1...282930...217 Page 29 of 217

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin